InnoCare Pharma (9969) Schedules Board Meeting for Third-Quarter 2025 Results

Bulletin Express

Oct 31

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any responsibility for the announcement’s contents, accuracy, or completeness.

InnoCare Pharma Limited (the “Company,” stock code: 9969) has scheduled a board meeting on Thursday, 13 November 2025 to consider and approve the unaudited results of the Company and its subsidiaries for the nine months ended 30 September 2025, along with related matters concerning the publication of those results. The announcement is dated 31 October 2025.

As of the date of the announcement, the board of directors comprises Chairperson and Executive Director, Dr. Jisong Cui; Executive Director, Dr. Renbin Zhao; Non-executive Directors, Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-executive Directors, Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1110866784"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110866784\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110866784?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110866784","market":"hk","top_or_hot":-1,"title":"InnoCare Pharma (9969) Schedules Board Meeting for Third-Quarter 2025 Results","media":"Bulletin Express","content":"<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any responsibility for the announcement’s contents, accuracy, or completeness.</p>\n<p>InnoCare Pharma Limited (the “Company,” stock code: 9969) has scheduled a board meeting on Thursday, 13 November 2025 to consider and approve the unaudited results of the Company and its subsidiaries for the nine months ended 30 September 2025, along with related matters concerning the publication of those results. The announcement is dated 31 October 2025.</p>\n<p>As of the date of the announcement, the board of directors comprises Chairperson and Executive Director, Dr. Jisong Cui; Executive Director, Dr. Renbin Zhao; Non-executive Directors, Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-executive Directors, Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InnoCare Pharma (9969) Schedules Board Meeting for Third-Quarter 2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoCare Pharma (9969) Schedules Board Meeting for Third-Quarter 2025 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-31 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any responsibility for the announcement’s contents, accuracy, or completeness.</p>\n<p>InnoCare Pharma Limited (the “Company,” stock code: 9969) has scheduled a board meeting on Thursday, 13 November 2025 to consider and approve the unaudited results of the Company and its subsidiaries for the nine months ended 30 September 2025, along with related matters concerning the publication of those results. The announcement is dated 31 October 2025.</p>\n<p>As of the date of the announcement, the board of directors comprises Chairperson and Executive Director, Dr. Jisong Cui; Executive Director, Dr. Renbin Zhao; Non-executive Directors, Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-executive Directors, Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1110866784","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110866784","pubTimestamp":1761902568,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any responsibility for the announcement’s contents, accuracy, or completeness. InnoCare Pharma Limited...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"诺诚健华医药(9969)安排董事会会议公布2025年第三季度业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any responsibility for the announcement’s contents, accuracy, or completeness.\nInnoCare Pharma Limited (the “Company,” stock code: 9969) has scheduled a board meeting on Thursday, 13 November 2025 to consider and approve the unaudited results of the Company and its subsidiaries for the nine months ended 30 September 2025, along with related matters concerning the publication of those results. The announcement is dated 31 October 2025.\nAs of the date of the announcement, the board of directors comprises Chairperson and Executive Director, Dr. Jisong Cui; Executive Director, Dr. Renbin Zhao; Non-executive Directors, Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-executive Directors, Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}